Please assess the completion status of the following clinical trial:

Trial Title: Intermittent Pneumatic Compression in Surgical Patients at Extremely-high Risk for Venous Thromboembolism

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age over 40~* Major surgery undergone\*~* High risk of postoperative VTE according to a National guideline\*\*~* 11+ Caprini scores~* Informed consent is given~Exclusion Criteria:~* Acute deep vein thrombosis (DVT) at baseline~* Performed inferior vena cava (IVC) plication or implanted IVC filter~* Regular preoperative anticoagulation~* Postoperative anticoagulation needed at therapeutic doses~* Absence of anticoagulation for more than 5 days after surgery~* Coagulopathy (not related to Disseminated intravascular coagulation syndrome)~* Thrombocytopenia~* Hemorrhagic diathesis~* Lower limb soft tissue infection~* Ankle-brachial index \< 0.6~  * Major surgery - intervention under endotracheal anesthesia with duration of more than 60 min.~    * In accordance with a standard stratification system, high risk of VTE group includes patients over 60 years old after major surgery and patients 40-60 years old with additional risk factors after major surgery.

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Experimental group (SCD + GCS + LMWH) (Type: EXPERIMENTAL): SCD: Intermittent pneumatic compression (IPC) with Kendall SCD™ Sequential Compression System 700 used continuously when the patient is in bed with 6-hours night interval free of compression: from 0 a.m. to 6 a.m. In the ICU SCD used continuously all day, and in surgery department - all time of bed resting. SCD used until discharge.~GCS: Thigh-length graduated compression stockings with pressure of 18-21 mm. Hg at the ankle used all the time until discharge plus one month after discharge~LMWH: LMWH enoxaparin (Clexane) 40 mg once a day subcutaneously started on 1st or 2-5th postoperative day according to the bleeding risk and used until discharge.
- Control group (GCS + LMWH) (Type: ACTIVE_COMPARATOR): GCS: Thigh-length graduated compression stockings with pressure of 18-21 mm. Hg at the ankle used all the time until discharge plus one month after discharge~LMWH: LMWH enoxaparin (Clexane) 40 mg once a day subcutaneously started on 1st or 2-5th postoperative day according to the bleeding risk and used until discharge.

Based on this trial design, predict the completion outcome and termination type (if applicable).